data science, infrastructure, and interdisciplinary teams to solve the most challenging antibody discovery problems.

Based on therapeutic area, the artificial intelligence (AI) in drug discovery market is segmented into oncology ... today ...

Completely artificial proteins that produce bioluminescence can serve as a non-invasive method for bioimaging, diagnostics, drug discovery, and more. Bioluminescence is the natural chemical process of ...

Schrödinger, Inc. (Nasdaq: SDGR) today announced financial results for the third quarter of 2024 and provided a business update. In a separate press release issued earlier ...

AlphaFold 3’s predecessor could predict protein structures The AI model is available for academic purposes only DeepMind ...

Parabilis Medicines, Inc. ("Parabilis") focused on supporting the clinical development of Parabilis' lead program, FOG-001, in colorectal cancer. This collaboration ...

Pfizer's head of digital devices says the industry is close to a 'revolution' in using measures from wearables in clinical ...

Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today highlighted pipeline ...